ANI Pharmaceuticals Inc (ANIP)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 284,819 285,032 285,244 285,457 285,669 285,882 286,095 286,307 286,520 186,063 189,525 168,985 172,443 175,161 177,879 188,094 175,808 64,873 65,688 66,501
Total stockholders’ equity US$ in thousands 432,749 429,861 409,622 314,632 313,690 311,825 312,108 321,244 333,890 191,403 191,917 203,712 195,700 195,100 191,344 201,171 212,791 213,130 207,656 199,712
Debt-to-capital ratio 0.40 0.40 0.41 0.48 0.48 0.48 0.48 0.47 0.46 0.49 0.50 0.45 0.47 0.47 0.48 0.48 0.45 0.23 0.24 0.25

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $284,819K ÷ ($284,819K + $432,749K)
= 0.40

The debt-to-capital ratio for ANI Pharmaceuticals Inc has shown fluctuation over the past eight quarters. In Q4 2023 and Q2 2023, the ratio stood at 0.40, indicating that 40% of the company's capital was financed by debt. This ratio decreased slightly from Q3 2023, where it was 0.39. However, it had been higher in Q1 2023 at 0.46.

Comparing these figures to the previous year, we observe that the company's debt-to-capital ratio has remained relatively stable since Q4 2022, where it stood at 0.46. This suggests that ANI Pharmaceuticals Inc has maintained a consistent level of debt relative to its capital structure over recent quarters.

Overall, the debt-to-capital ratio indicates that ANI Pharmaceuticals Inc relies moderately on debt to finance its operations and investments, with fluctuations seen in recent quarters. Investors and analysts may monitor this ratio to assess the company's leverage and financial risk over time.